Franklin Biotechnology Discovery Fund

Portfolio Statistics

Assets

Total Fund AssetsAs of 04/30/2021 (updated monthly) $1,449.3 (M)
Net Assets - Class R6 As of 03/31/2021 (updated monthly) $16.5 (M)

Positions As of 04/30/2021

Equity VS. NASDAQ Biotechnology Index

Fund Benchmark
Market CapitalizationAs of 04/30/2021 (updated monthly) $26,471.93(M) $40,563.81(M)
P/B RatioAs of 04/30/2021 (updated monthly) 5.21 5.89
P/E Ratio (12-mo Forward)As of 04/30/2021 (updated monthly) 13.93 13.51
Price to Cash FlowAs of 04/30/2021 (updated monthly) 15.35 15.26

Portfolio Details

Asset AllocationAs of 04/30/2021

[name] [value]
Equity 96.21%
Cash & Cash Equivalents 3.79%

Geographic BreakdownAs of 04/30/2021

[name] [value]
United States 89.68%
Cash & Cash Equivalents 3.79%
Denmark 2.23%
Canada 1.86%
Switzerland 1.18%
Netherlands 1.12%
United Kingdom 0.14%

sector breakdownAs of 04/30/2021

[name] [value]
Biotechnology 79.42%
Pharmaceuticals 10.60%
Life Sciences Tools & Services 4.09%
Cash & Cash Equivalents 3.79%
Diversified Capital Markets 1.62%
Other Diversified Financial Services 0.35%
Health Care Facilities 0.14%

TOP TEN HOLDINGSAs of 04/30/2021

Issuer Country Industry % of total
GILEAD SCIENCES INC United States Pharmaceuticals, Biotechnology & Life Sciences 6.08%
AMGEN INC United States Pharmaceuticals, Biotechnology & Life Sciences 5.27%
REGENERON PHARMACEUTICALS INC United States Pharmaceuticals, Biotechnology & Life Sciences 4.59%
VERTEX PHARMACEUTICALS INC United States Pharmaceuticals, Biotechnology & Life Sciences 4.23%
ILLUMINA INC United States Pharmaceuticals, Biotechnology & Life Sciences 4.09%
NOVAVAX INC United States Pharmaceuticals, Biotechnology & Life Sciences 3.95%
HORIZON PHARMA PLC United States Pharmaceuticals, Biotechnology & Life Sciences 3.56%
BIOGEN INC United States Pharmaceuticals, Biotechnology & Life Sciences 3.13%
IOVANCE BIOTHERAPEUTICS INC United States Pharmaceuticals, Biotechnology & Life Sciences 3.03%
MIRATI THERAPEUTICS INC United States Pharmaceuticals, Biotechnology & Life Sciences 2.45%

Market Capitalization BreakdownAs of 04/30/2021

[name] [value]
<2.0 Billion 24.17%
2.0-5.0 Billion 18.89%
5.0-10.0 Billion 15.99%
10.0-25.0 Billion 10.13%
25.0-50.0 Billion 3.25%
>50.0 Billion 26.44%
N/A 1.12%